SES · 8K7.SI
UG Healthcare Corporation Limited
SGD 0.08-SGD 0.00 (-1.32%)
UG Healthcare Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 31.82% below the high.
Loading market information…
SES · 1B1.SI · SGD
Stock price, dividends
Quote as of Oct 30, 2026, 07:21 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SGD. Historical prices are not a forecast.
HC Surgical Specialists Limited’s quoted price sits in the lower half of its reported 52-week range, 15.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
HC Surgical Specialists Limited’s forward annual dividend is SGD 0.02 per share, paid semi-annual. The forward yield is 6.94% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
HC Surgical Specialists Limited, an investment holding company, primarily delivers a diverse spectrum of medical services across Singapore. Through its network of clinics, the company specializes in endoscopic procedures, such as gastroscopies and colonoscopies, in addition to providing general surgical services with a notable focus on colorectal issues. Their expertise further extends to treating a variety of conditions, including haemorrhoids, anal fissures, hernias, anal abscesses, cholecystitis, anal fistulas, appendicitis, colorectal and gastric cancers, lipomas, and cysts, utilizing advanced techniques like vein laser vascular therapy and laparoscopy. Moreover, the company offers extensive orthopedic services. These address concerns such as joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, tenosynovitis, tunnel syndrome, and various wounds or lumps. Surgical interventions include joint replacements, arthroscopic procedures, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, and fracture management, supported by orthobiologic injections. Beyond clinical care, the company provides comprehensive home care services, encompassing medical, nursing, physiotherapy, speech, occupational therapy, and ambulance support. Their community health initiatives include health screenings, management of acute and chronic conditions, pre-employment check-ups, and participation in public health schemes such as the 'swab and send home' program, the community health assist scheme, and COVID-19 testing. To support accurate diagnosis, a full array of diagnostic tests is available, including blood work, X-rays, ultrasounds, CT scans, and MRIs. The company was founded in Singapore in 2015, where it continues to be headquartered.
Latest available per-share figures in SGD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SGD 0.08-SGD 0.00 (-1.32%)
UG Healthcare Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 31.82% below the high.
SGD 0.02-SGD 0.00 (-7.69%)
Embracing Future Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 73.91% below the high.
SGD 0.02+SGD 0.00 (+15.0%)
Singapore Institute of Advanced Medicine Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 74.16% below the high.
SGD 0.07SGD 0.00 (0.0%)
Vicplas International Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.64% below the high.
SGD 0.23SGD 0.00 (0.0%)
Niks Professional Ltd’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
SGD 0.20SGD 0.00 (0.0%)
Medinex Limited’s quoted price sits in the lower half of its reported 52-week range, 21.57% below the high.
SGD 0.05-SGD 0.00 (-6.25%)
Medi Lifestyle Limited’s quoted price sits in the lower half of its reported 52-week range, 53.13% below the high.
SGD 0.09-SGD 0.00 (-1.09%)
Cordlife Group Limited’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
